Business Context and Reporting Period
Company: Virtuix Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 29, 2026
Reporting Period: Specific event date of June 29, 2026.
Business Context: The Company entered into material definitive agreements to amend existing warrants held by Streeterville Capital, LLC.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, debt levels, or liquidity ratios. The filing focuses exclusively on the terms of warrant amendments.
Material Changes
The primary material change reported is the amendment of the exercise price for three specific warrants issued to Streeterville Capital, LLC:
- Warrants Amended:
- Equity Financing Warrant (originally dated August 25, 2025).
- Second Debt Financing Warrant (originally dated October 30, 2025).
- Third Debt Financing Warrant (originally dated December 19, 2025).
- Price Adjustment: The exercise price was reduced from $4.00 per share to $3.00 per share.
- Terms: The "Reduced Exercise Price Period" and expiration date (July 27, 2026) remain unchanged.
- Termination Clause: The Company retains the right to terminate the Reduced Exercise Price Period with two trading days' prior written notice, at which point the exercise price reverts to the Nasdaq Valuation Price.
Guidance, Outlook, and Risks
Management Commentary: The filing contains no forward-looking guidance, outlook, or general management commentary beyond the description of the warrant amendments.
Risks and Contingencies: The filing notes that the Company may terminate the reduced exercise price period, causing the price to revert to the Nasdaq Valuation Price. No other specific risks or contingencies are detailed in this report.
Investor Verification Checklist
- Verify the full text of the Warrant Amendments filed as Exhibits 4.1, 4.2, and 4.3 to confirm all terms and conditions.
- Confirm the current Nasdaq Valuation Price to understand the potential exercise price if the Company terminates the Reduced Exercise Price Period.
- Review the total number of shares underlying the three amended warrants to assess potential dilution at the new $3.00 exercise price.
- Check the Company's recent stock price relative to the $3.00 exercise price to determine if the warrants are currently in-the-money.